Litigation Details for AstraZeneca AB v. Macleods Pharmaceuticals Ltd. (D. Del. 2020)
✉ Email this page to a colleague
AstraZeneca AB v. Macleods Pharmaceuticals Ltd. (D. Del. 2020)
Docket | ⤷ Try a Trial | Date Filed | 2020-09-03 |
Court | District Court, D. Delaware | Date Terminated | 2020-10-26 |
Cause | 35:271 Patent Infringement | Assigned To | Richard Gibson Andrews |
Jury Demand | None | Referred To | |
Patents | 10,300,065 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in AstraZeneca AB v. Macleods Pharmaceuticals Ltd.
Details for AstraZeneca AB v. Macleods Pharmaceuticals Ltd. (D. Del. 2020)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2020-10-26 | 13 | Patent/Trademark Report to Commissioner of Patents | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,300,065. (Attachments: # 1…2020 26 October 2020 1:20-cv-01180 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
2020-09-03 | 4 | Patent/Trademark Report to Commissioner of Patents | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,300,065. (nmg) (Entered: 09…2020 26 October 2020 1:20-cv-01180 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |